MUPIROCIN 100MG
|
Mupirocin, 92%, C26H44O9, CAS Number-12650-69-0, 100mg, 672 deg.C, CHEBI:7025, White, >110 deg.C (230 deg.F), 500.62, MINDHVHHQZYEEK-HBBNESRFSA-N, 9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]
|
3429-J66347MC
|
EA
|
|
Mupirocin, 92% 50mg
|
Mupirocin, 92% 50mg
|
3136-J66347MF
|
EA
|
|
Mupirocin lithium salt 100mg
|
Mupirocin lithium salt 100mg
|
3136-J66890MC
|
EA
|
|
MUPIROCIN 100MG
|
Mupirocin, >-98.0% (T), C26H44O9, CAS Number-12650-69-0, centany, mupirocina, plasimine, mupirocine, mupirocinum, mupirocin, bactroban, pseudomonic acid, pseudomonic acid a, bactoderm, 100mg, CHEBI:7025, White, 500.63, MINDHVHHQZYEEK-HBBNES
|
3113-M2955100MG
|
EA
|
|
MUPIROCIN LITH SLT 100MG
|
Mupirocin lithium salt, 95%, C26H43LiO9, CAS Number-73346-79-9, 100mg, 506.55, XFIKMPRBSORKQP-JATHGWPISA-M, lithium;9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2
|
3429-J66890MC
|
EA
|
|
Mupirocin >=92% (HPLC), powder
|
Mupirocin >=92% (HPLC), powder
|
3042-M7694100MG
|
EA
|
|
Mupirocin >=92% (HPLC), powder
|
Mupirocin >=92% (HPLC), powder
|
3042-M769450MG
|
EA
|
|
Mupirocin lithium
|
Mupirocin lithium United States Pharmacopeia (USP) Reference Standard
|
3042-1448923100MG
|
EA
|
|
Mupirocin
|
Mupirocin United States Pharmacopeia (USP) Reference Standard
|
3042-144890150MG
|
EA
|
|